REFILE-Stryker lifts 2024 profit forecast on strong demand for medical devices, implants

(Adds media packaging code)

April 30 (Reuters) - Stryker Corp lifted its full-year profit forecast on Tuesday, owing to resilient demand for the company's medical devices and implants.

The joint-implant maker now sees its annual profit per share to be between $11.85 and $12.05, raised from the previous range of between $11.70 and $12. The analysts' average estimate for 2024 is pegged at $11.85 per share.

Demand for medical implants has received a boost as more people, especially older adults, opt for surgeries deferred during the pandemic

Stryker now expects organic net sales growth for 2024 to be in the range of 8.5% to 9.5%, compared with its earlier projected range of 7.5% to 9%.

The company reported a 9.7% rise in quarterly revenue to $5.24 billion, compared with estimates of $5.10 billion, according to LSEG data.

On an adjusted basis, it reported a profit of $2.50 per share for the quarter ended March 31, above analysts' estimate of $2.35 per share. (Reporting by Unnamalai L and Pratik Jain in Bengaluru; Editing by Mohammed Safi Shamsi)